Ibugel (Ibuprofen)

Ibuprofen in Ibugel inhibits the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in the skin and underlying tissues. This inhibition reduces the synthesis of prostaglandins, which are key mediators of pain, inflammation, and fever, thereby delivering localized relief without significant systemic exposure.

The appropriate amount of Ibugel to apply is determined by the prescribing healthcare professional based on the size of the affected area, severity of symptoms, and individual patient factors. Patients should follow the specific instructions provided by their prescriber or pharmacist.

Safety of topical ibuprofen during pregnancy or lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss the use of Ibugel with their physician to weigh potential benefits against any possible risks.

To request Ibugel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Ibugel contains ibuprofen, a widely studied NSAID with a well‑characterized safety profile. Compared with other topical NSAIDs such as diclofenac or ketoprofen gels, ibuprofen offers similar anti‑inflammatory potency but may differ in skin absorption rates and formulation characteristics, influencing onset of relief and tolerability.

Store Ibugel at room temperature, preferably below 25 °C. Keep the gel in its original packaging, protect it from moisture, direct sunlight, and extreme temperatures to maintain product stability and efficacy.

Clean and dry the affected skin area before use. Apply a thin layer of the gel to the target region and gently rub it in until fully absorbed. Avoid covering the area with occlusive dressings unless directed by a healthcare professional.

Although uncommon, serious adverse reactions can include severe allergic dermatitis, Stevens‑Johnson syndrome, systemic gastrointestinal ulceration, renal impairment, hepatic dysfunction, and anaphylaxis. Any signs of widespread rash, swelling, difficulty breathing, or unexplained gastrointestinal symptoms should prompt immediate medical attention.

Ibugel should be avoided by individuals with known hypersensitivity to ibuprofen or any component of the gel, those with broken, infected, or severely damaged skin at the intended application site, and patients who have been advised against NSAID use by their physician due to underlying medical conditions.